Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · Common medical writing mistakes

Common Mistakes in Medical Writing for Clinical Research: Reporting Errors and Their Prevention

Most manuscripts are rejected before peer review. Jawaid and Jawaid report that between 70% and 80% of submissions to their journal are not processed further after initial screening and editorial triage, across 17 distinct recorded reasons. Almost none of these reasons concern language.

Pubrica AcademyWritten by the medical writing and biostatistics teams Reviewed byPubrica biostatistics team Published9 October 2026 Last checked9 October 2026 Reading time13 minutes Sources29 peer-reviewed

The term “mistake” in medical writing is usually understood as a language problem, which is why considerable author effort is misdirected. The errors that prevent acceptance are errors of reporting: a claim the design cannot support, a methods section that requests the reviewer’s trust, an outcome that changed without disclosure between protocol and paper, or an abstract that omits numerical results. This article identifies the recurring errors, the section in which each occurs, and which can be corrected at the writing stage and which were determined at the design stage.

Learning objectives

  • The stage at which errors are detected: 70–80% of submissions stopped at screening and triage, across 17 recorded reasons
  • The six most frequently recurring reporting errors, and the manuscript section in which each occurs
  • The reasons “appropriate statistical tests” is a particularly costly phrase in a methods section
  • The interpretation by reviewers of outcome switching and unlabelled exploratory analysis
  • The reasons an undisclosed writing contribution constitutes a compliance failure rather than a lapse of courtesy
  • The problems that editing can and cannot address

Common misconceptions

  • “My English is the problem.” Jawaid and Jawaid’s list of 17 triage reasons is dominated by what was studied and how it was reported. Non-native phrasing is rarely the decisive objection once the reporting is sound.
  • “Hedging protects me.” A phrase such as “May suggest a possible role” does not render a claim safe; it renders it unassessable, and an editor reading quickly is likely to conclude that there is no finding.
  • “The title, abstract and keywords are packaging.” They are the only part most readers see and, in practice, the point at which triage occurs. Fujita and colleagues found that author guidance on these elements is itself inconsistent, with abstracts addressed by 97% of journals in one field against 72% in another, so expectations must be inferred from published papers rather than assumed to be absent.
  • “Word limits can be negotiated.” Where a journal publishes a section-by-section allowance (Radiology specifies 400 words of introduction and 1,000 of results within a 3,000-word limit), the allocation is an editorial statement of priorities.
  • “Acknowledging a writer looks weak.” It is a requirement. Wager and colleagues found acknowledgement reported by 96% of industry, 99% of agency and 100% of contract research organisation respondents, yet 11% to 13% knew of academic authors who initially refused to acknowledge writing support.

Stages at which manuscript errors are detected

Before the errors are listed, it is useful to establish who detects them and at what stage. Jawaid and Jawaid, writing in Pakistan Journal of Medical Sciences, describe their journal’s screening and triage process and report that between 70% and 80% of submissions are not processed further after initial screening and the editor’s triage 7. They set out 17 distinct reasons for rejecting a manuscript without sending it to external peer review. In the retrospective analysis cited in that editorial, of 1,000 submitted manuscripts, 902 had reached a decision and 552 of those were rejected after initial screening 7,28.

Two practical conclusions follow. First, the reader whom authors must satisfy is an editor working quickly rather than a reviewer working carefully; consequently, the title, abstract and methods carry disproportionate weight because they are the sections that are read 7. Second, the consequential errors are those visible on rapid reading: a claim that does not match the design, an unnamed outcome, a missing ethics statement, or a manuscript that exceeds the length limit by a third. Subtle problems in the discussion are a concern for peer review; they rarely cause a manuscript to be stopped at triage.

Language is not irrelevant. It is, however, the last of several filters, and authors frequently pay to clear the last filter while leaving the earlier ones unaddressed.

70–80%of submissions not processed further after screening and triage
17distinct reasons for rejection without external review
552of 902 decided manuscripts rejected after initial screening

One journal’s screening and triage process, from a retrospective analysis of 1,000 submitted manuscripts of which 902 had reached a decision. Source: Jawaid SA, Jawaid M. Common reasons for not accepting manuscripts for further processing after editor’s triage and initial screening. Pakistan Journal of Medical Sciences.

Claims unsupported by the study design

This error is the most common and the most costly, and it takes two forms. The first is overclaiming: a cross-sectional association reported as an effect, a before-and-after comparison reported as evidence that the intervention was effective, or a subgroup difference reported as a finding about who benefits. The second is the opposite failure: hedging so extensive that no claim survives. “Our results may suggest a possible role for further investigation” is not caution but an absence of content, and an editor is likely to read it as such.

A simple test can be applied during writing. The claim is stated in one sentence and, beneath it, the design feature that justifies the claim. If the second sentence is weak (for example, “because the two groups differed”), the claim should be narrowed until the justification is adequate. A bounded claim is stronger than a vague one because a reviewer is able to agree with it.

Where causal language is in question, the relevant reporting guideline usually resolves the matter. Von Elm and colleagues’ STROBE statement, in the BMJ, is explicit that observational studies should discuss the direction and magnitude of potential bias rather than assert effects; Schulz, Altman and Moher’s CONSORT 2010 statement in Trials sets the parallel expectations for randomised trials 16,19. Our reporting guidelines page maps designs to checklists.

Insufficiently detailed methods

“Data were analysed using appropriate statistical tests. P<0.05 was considered significant.” These two sentences appear in a very large number of submitted manuscripts, and they have the opposite of the intended effect. A methods section exists so that a reader can judge whether the analysis was adequate; a sentence that asks the reader to assume adequacy removes the only grounds on which the reader could have agreed.

The same failure recurs in several specific forms: sampling or allocation described without stating who held the sequence or how eligibility was applied; an unnamed analysis population, so that a reader cannot determine whether the analysis was by intention to treat or per protocol; unmentioned missing data, which a reviewer reads by default as complete-case analysis and therefore as a source of bias; multiple testing without any statement of how it was handled; and named outcomes measured with an instrument whose validation status is not reported.

The last of these merits particular attention because it is so widely overlooked. Where an outcome is patient-reported, the instrument forms part of the measurement chain and must be described: Churruca and colleagues, in Health Expectations, review the generic and condition-specific landscape and the problems that arise when instruments are chosen without regard to what they were validated to measure 5. The US Food and Drug Administration’s guidance on patient-reported outcome measures sets out what is expected where such a measure supports a labelling claim 2. Neither is a writing document, but both define what the methods must say.

Where the analysis itself, rather than its description, is the weakness, the remedy is not editorial. The biostatistics page covers that case.

Undisclosed outcome switching

A protocol names a primary outcome. A manuscript reports three outcomes, the significant one first, and does not state which was primary. Even where no impropriety occurred, this is read as outcome switching, and reviewers are now more alert to it than they were twenty years ago.

The errors in this category are variations on a single theme: reporting secondary outcomes before the primary outcome; describing an analysis as planned when it was not; presenting a subgroup finding without an interaction test, or with an interaction test that was not significant; introducing a number in the discussion that does not appear in the results; and reporting a composite outcome without its components, or components without the composite, according to which appears more favourable.

The remedy is procedural rather than editorial: every analysis should be labelled as pre-specified or exploratory, the primary outcome should be reported first and identified as primary, and the registration identifier should be included in the methods so that a reader can verify it. Sterne and colleagues’ RoB 2 tool in the BMJ is the instrument a reviewer will use to judge bias in a trial, and selective reporting is one of its domains; the methods should therefore be written to supply the information that RoB 2 requires 9. Where certainty of evidence is being graded, Guyatt and colleagues’ GRADE papers in the BMJ and the Journal of Clinical Epidemiology govern how that is expressed 15,18.

This is also the clearest example of an error that cannot be corrected by writing. An outcome that was not pre-specified cannot be made pre-specified during drafting. The appropriate course is to label it exploratory and allow the reader to weigh it accordingly.

Underestimation of the title, abstract and keywords

These three elements are what triage reads, what searches return and what potential citing authors see; they are also where authors invest the least effort. The recurring errors are specific: a title that names a topic rather than a finding or a design; an abstract that devotes its first third to background already familiar to the field; a primary outcome reported as a direction rather than a number; a conclusion that exceeds what the results support; and keywords that duplicate words already in the title and therefore add nothing to retrievability.

Huth, in the Annals of Internal Medicine, argued for structured abstracts in trial reports because an unstructured abstract allows an omission (the design, the population or the effect size) to pass unnoticed 25. The structure makes such gaps conspicuous, which is uncomfortable for authors but useful.

Journal guidance here is less reliable than authors assume. Fujita, Agustín-Lacruz and Terra examined 64 journals indexed in Journal Citation Reports and found author guidance uneven: abstracts were addressed by 97% of Communication Science journals but 72% of Library and Information Science journals, titles by 72% against 53%, and keywords by 88% against 66% 10. Silence in the instructions does not mean that the expectation is absent; the expectation must instead be inferred from recently published papers in that journal 10. Our abstract writing page covers the structured forms.

Neglect of the word allocation

Writing a 5,200-word manuscript for a 3,000-word limit and then cutting it is likely to produce a weak paper, because the material cut under deadline is whatever is easiest to remove rather than whatever matters least, usually methods detail and limitations 28.

Some journals publish the allocation, which makes editorial priorities explicit. Radiology’s author instructions cap Original Research at 3,000 words and divide it: a 15-word title, a 30-word summary statement, 75 words of key results, a 300-word abstract, a 400-word introduction, 800 words of materials and methods, 1,000 words of results, 800 words of discussion, and a maximum of 35 references 7. Results receive the largest share, methods and discussion are equal, and the introduction is deliberately short 28.

Underneath the word count sits a paragraph plan. Kliewer, in the American Journal of Roentgenology, describes a typical manuscript as approximately 18 paragraphs across five sections, with three introduction paragraphs before the purpose statement and five discussion paragraphs before the summary, and observes that a manuscript usually requires around four drafts before it is of good quality 20. When a manuscript is planned to the paragraph count, the word count ceases to be a difficulty. The Pubrica guide to medical paper structure works through the section-by-section logic.

Failures of attribution and disclosure

These errors concern process more than skill, and they are the ones that lead to corrections and retractions. The list is short and almost entirely avoidable: references cited from a secondary source rather than read; a reference manager export that does not match the original; authorship that includes someone who did not meet all four ICMJE criteria, or excludes someone who did; text reused from the authors’ own earlier paper without quotation or citation; an undeclared funding source or conflict of interest; and a missing ethics approval or consent statement 1.

Undisclosed professional writing support belongs in this list, and survey evidence indicates how established the norm now is. Wager and colleagues’ Global Publication Survey in BMJ Open collected responses from 469 publication professionals across 23 countries. Acknowledgement of medical writing support was reported by 96% of industry respondents, 99% of agency respondents and 100% of those at contract research organisations 12. Yet 11% to 13% knew of academic authors who had initially refused to be acknowledged, which indicates that the remaining resistance comes from authors rather than from sponsors or writers 12.

The ICMJE position is that contributors who do not meet all four authorship criteria are acknowledged, with their contribution described, and that includes writing assistance 1. The same survey found 93% of respondents routinely referring to the ICMJE requirements and 91% to Good Publication Practice. Authors who used writing support should name it; the disclosure has no cost, and its absence counts against the authors. The Pubrica page on outsourcing medical writing sets out what the obligation involves.

Example of an appropriately bounded conclusion

The claim-to-design mismatch is best illustrated in text, because it is rarely obvious to the author. The weak version is not poorly written; it is a conclusion that implicitly upgrades what the design can show, and each upgrade is a separate potential objection.

The same observational result, concluded two ways (a constructed specimen — the figures are illustrative, not results from a real study)

Claims more than the design allows

In conclusion, our study demonstrates that early mobilisation improves functional outcomes in patients admitted with acute medical illness, and suggests that early mobilisation protocols should be implemented routinely. The benefit appeared particularly marked in older patients, indicating that this group stands to gain most. These findings have important implications for clinical practice and may suggest a possible role for further investigation in other settings.

“Demonstrates” and “improves” assert causation from an observational design — the single objection most likely to be raised.

A recommendation the design cannot carry. “Should be implemented routinely” is a guideline-level claim from one cohort.

An unlabelled subgroup claim. “Particularly marked in older patients” with no interaction test reads as selective reporting.

Hedging that cancels the content. “May suggest a possible role” leaves no claim for a reader to assess.

Confounding never named. Silence on the most obvious alternative explanation invites the reviewer to supply it.

Bounded by the design

In this single-centre retrospective cohort, patients mobilised within 24 hours of admission had higher discharge functional scores than those mobilised later (adjusted difference 4.1 points; 95% CI 1.3 to 6.9). The association persisted after adjustment for age, admission severity and comorbidity, but the design cannot exclude confounding by indication: patients able to mobilise early may have been less unwell in ways our covariates did not capture. The age interaction was not pre-specified and was not significant (P=0.34); we report it as exploratory. These findings support a randomised evaluation, not a change in protocol.

The effect is given as an adjusted difference with an interval, so it can be compared with other studies.

The design is named, and the specific confounding mechanism is stated rather than left for the reviewer to raise.

The subgroup analysis is labelled exploratory and its non-significant test reported.

The recommendation is scaled to the evidence: a trial, not a protocol change.

The second version makes a smaller claim and is considerably harder to dispute, which is why it constitutes the stronger paper. Every objection the first version invites (causation from association, an untested subgroup, an unaddressed confounder and an unsupported recommendation) is pre-empted. The items correspond to STROBE’s expectations for discussing bias and generalisability, so the checklist can serve as the drafting prompt.

Scope and limitations of editing

The boundary should be stated plainly, because authors frequently commission the wrong service. Editing can correct unclear sentences, inconsistent terminology, a results section whose order does not match the methods, interpretation that has drifted into the results, a conclusion that overreaches, missing reporting-guideline items where the information exists but was not written down, reference formatting, and length. These are genuine problems that merit correction. Developmental editing addresses the structural end of that list; copy-editing and proofreading the sentence end.

Editing cannot correct a question the design cannot answer, an underpowered sample, an outcome that was not pre-specified, a control group that was never recruited, an instrument that measures something other than what is claimed, or missing ethics approval. These are problems of the study, and language editing applied to them produces a well-written manuscript that attracts the same objections.

There is also no good evidence that editing raises acceptance rates. The training literature supports a narrower but genuine conclusion: Fernandez and colleagues, in BMJ Open, followed 741 students across 27 editions of a 15-hour scientific writing course and found mean satisfaction of 4.6 out of 5 with self-rated gains of 1.6 points for knowledge, 1.3 for attitudes and 1.4 for skills on a 0–4 scale, all at P<0.001 — self-reported gains in capability, not publication outcomes 28. Bloothooft and colleagues, in BMC Medical Education, report on example-based training built around reviewing real manuscripts, and Borowiec, in PLOS Computational Biology, sets out ten rules for scientists communicating their work 3,4. Taken together, they suggest that the most reliable way to avoid these errors is to read other authors’ manuscripts as a reviewer would 3,29.

The recurring mistakes, where they live, and whether writing can fix them

MistakeSection it lives inFixable at the writing stage?
Claim exceeds what the design supportsAbstract, discussionYes — narrow the claim to what the design entitles
Claim hedged into nothingAbstract, discussionYes — state the finding with its bounds
“Appropriate statistical tests”MethodsYes, if the analysis was sound; no, if it was not
Analysis population or missing data unstatedMethodsYes, if the information exists
Instrument validation status unreportedMethodsYes, if a validated instrument was used
Primary outcome unnamed or reported lateMethods, resultsYes — name it and report it first
Exploratory analysis presented as plannedResultsPartly — label it exploratory; the status cannot change
New numbers appearing in the discussionDiscussionYes — move them into the results
Generic limitations with no direction of biasDiscussionYes — state which way each would bias the estimate
Over length, cut under deadlineWhole manuscriptYes, but better prevented with a section budget
Authorship or acknowledgement non-compliantFront and back matterYes — apply the four ICMJE criteria and acknowledge the rest
Writing support undisclosedAcknowledgementsYes — and required
Underpowered sample; outcome never pre-specifiedDesignNo. This was settled before drafting

Compiled from the reporting requirements in CONSORT 2010, PRISMA 2020 and STROBE, the ICMJE Recommendations, and the triage reasons described by Jawaid SA, Jawaid M in Pakistan Journal of Medical Sciences. The right-hand column represents Pubrica’s assessment, not a finding from a study.

Key points

Key points

The errors that prevent acceptance are errors of reporting rather than of language. Most submissions never reach a reviewer: Jawaid and Jawaid report that 70% to 80% are stopped after screening and triage, across 17 recorded reasons. The consequential errors are therefore those visible on rapid reading: a claim the design cannot support, a methods section that requests trust rather than supplying detail, an unnamed primary outcome, an abstract without numerical results, and missing disclosures. Each can be corrected during drafting and is less costly to prevent than to contest afterwards. Errors that cannot be corrected, such as an underpowered sample or an outcome that was not pre-specified, should be identified early so that editing resources are not expended on them.

Application to your study

Application to your study

  1. State the claim in a single sentence, followed by the design feature that justifies it. If the justification is weak, narrow the claim until it is accurate.
  2. Remove the phrase “appropriate statistical tests”. Replace it with the named test for each outcome, the analysis population and the method used to handle missing data.
  3. Identify the primary outcome as primary and report it first. Label every other analysis explicitly as pre-specified or exploratory.
  4. Report the registration identifier in the methods. It should not appear only in the submission form, where readers cannot see it.
  5. Verify every number in the discussion against the results. Any number appearing for the first time is likely to be read as post hoc.
  6. State the direction of each limitation. Indicate whether it would inflate or attenuate the estimate; a list without directions functions only as a disclaimer.
  7. Revise the abstract so that the first sentence after the objective contains a numerical result. Reduce the background to fit the word limit.
  8. Apply the ICMJE authorship criteria to every named author. All four criteria should be met by each author; all other contributors, including providers of writing support, should be acknowledged.
  9. Verify references against the original sources rather than against a reference manager export. Citation errors are easily made and readily detected.
  10. Before commissioning editing, classify problems as correctable or structural. Language editing of a manuscript with a design problem produces a well-written manuscript that attracts the same objections.

Frequently asked questions

Making a claim the design cannot support. The error appears in two forms: overclaiming, as when a cross-sectional association is reported as an effect or a before-and-after comparison as evidence that an intervention was effective, and the opposite failure of hedging so heavily that no claim survives for a reader to assess. Both are detected quickly. Jawaid and Jawaid, in Pakistan Journal of Medical Sciences, report that between 70% and 80% of submissions to their journal are not processed further after initial screening and triage, across 17 distinct recorded reasons, most of which concern what was studied and how it was reported rather than the prose.

It can contribute, but it is rarely the decisive objection once the reporting is sound, and it is the filter on which authors spend disproportionately. The reasons recorded at triage concern the question, the design, the completeness of the methods and the fit with the journal. Where language genuinely obscures what was done, it becomes a reporting problem and merits correction; however, correcting it does not address an objection to the sample size or the outcome definition. Problems should be classified first: if the issue concerns structure rather than sentences, developmental editing is the relevant service, and if it concerns the analysis, editing will not help.

The methods section exists so that a reader can judge whether the analysis was adequate, and that phrase asks the reader to assume that it was. It removes the only grounds on which a reviewer could have agreed with the authors. It should be replaced with the named test for each outcome, the analysis population (intention to treat, per protocol, complete case), the handling of missing data, and any adjustment for multiple testing. The same reasoning applies to “patients were randomised” with no statement of who held the allocation sequence, and to a patient-reported outcome whose instrument is named but whose validation status is not reported.

Authors should state whether it was pre-specified, report the interaction test, and label it exploratory where appropriate. A subgroup difference presented without an interaction test, or with a non-significant test omitted, is read as selective reporting whether or not any impropriety occurred, and reviewers are now more alert to this than they were twenty years ago. Selective reporting is an explicit domain in Sterne and colleagues’ RoB 2 tool, published in the BMJ, which is the instrument a reviewer will use to assess bias in a trial. Writing the methods to supply the information RoB 2 requires is the least costly protection available.

Yes. Contributors who do not meet all four ICMJE authorship criteria are acknowledged, with their contribution described, and professional writing assistance falls within that category. The norm is well established in practice: Wager and colleagues’ Global Publication Survey in BMJ Open, covering 469 publication professionals in 23 countries, found acknowledgement reported by 96% of industry respondents, 99% of agency respondents and 100% of those at contract research organisations. Notably, 11% to 13% knew of academic authors who had initially refused to be acknowledged, which suggests that the residual resistance comes from authors rather than from sponsors or writers. Omitting the disclosure is a compliance failure, whereas the disclosure itself has no cost.

Length should be decided before drafting rather than afterwards. Where a journal publishes its allocation, its proportions provide a useful model: Radiology caps Original Research at 3,000 words divided into a 300-word abstract, a 400-word introduction, 800 words of methods, 1,000 words of results and 800 words of discussion, with a 15-word title, a 30-word summary statement, 75 words of key results and a maximum of 35 references. Underneath that, Kliewer, in the American Journal of Roentgenology, describes approximately 18 paragraphs across five sections, three in the introduction before the purpose statement and five in the discussion before the summary. Cutting a finished draft by a third tends to remove methods detail and limitations, which is precisely the material that should be retained.

Any problem determined when the study was designed: an underpowered sample, a control group that was never recruited, an outcome that was not pre-specified, an instrument that measures something other than what is claimed, a question the design cannot answer, or absent ethics approval. Language editing applied to any of these produces a well-written manuscript with precisely the same objections, and problems should therefore be classified before any service is commissioned. There is also no peer-reviewed evidence that editing raises acceptance rates; what editing reliably achieves is the removal of avoidable objections and the presentation of a sound study in a form that a rapid reader can follow.

Reading other authors’ manuscripts as a reviewer would is the least costly form of training and the one with the clearest rationale. The formal literature supports gains in capability rather than in publication outcomes: Fernandez and colleagues, in BMJ Open, followed 741 students across 27 editions of a 15-hour scientific writing course and found self-rated gains of 1.6 points for knowledge, 1.3 for attitudes and 1.4 for skills on a 0–4 scale, all at P<0.001, with mean satisfaction of 4.6 out of 5. These gains are self-reported. Bloothooft and colleagues, in BMC Medical Education, describe example-based training built around reviewing real papers, which is the approach most consistent with what the triage data suggests matters.

References

  1. International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. 2026. read 9 October 2026. icmje.org
  2. US Department of Health and Human Services, Food and Drug Administration (CDER, CBER, CDRH). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. read 9 October 2026. hhs.gov
  3. Bloothooft M, Pennings HJM, van der Heyden MAG. The Utrecht University Honours Program review project: example based scientific publishing training aimed at bachelor medical students. BMC Medical Education. 2024;24(1):1-12. doi:10.1186/s12909-024-05098-7 read 9 October 2026. doi.org/10.1186/s12909-024-05098-7
  4. Borowiec BG. Ten simple rules for scientists engaging in science communication. PLOS Computational Biology. 2023;19(7):e1011251. doi:10.1371/journal.pcbi.1011251 read 9 October 2026. doi.org/10.1371/journal.pcbi.1011251
  5. Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LED, Leahy CJ, Braithwaite J. Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expectations. 2021;24(4):1015-1024. doi:10.1111/hex.13254 read 9 October 2026. doi.org/10.1111/hex.13254
  6. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71. doi:10.1136/bmj.n71 read 9 October 2026. doi.org/10.1136/bmj.n71
  7. Jawaid SA, Jawaid M. Common reasons for not accepting manuscripts for further processing after editor's triage and initial screening. Pakistan Journal of Medical Sciences. 2019;35(1):1-3. doi:10.12669/pjms.35.1.28 read 9 October 2026. doi.org/10.12669/pjms.35.1.28
  8. Pasarica M, Bailey M, Cendan JC. Increasing students' publication productivity: could launching a university scientific journal be a catalyst? Cureus. 2019;11(1):e3953. doi:10.7759/cureus.3953 read 9 October 2026. doi.org/10.7759/cureus.3953
  9. Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. read 9 October 2026. frontiersin.org
  10. Fujita MSL, Agustin-Lacruz MdC, Terra AL. Journals' guidelines about title, abstract and keywords: an overview of Information Science and Communication Science areas. European Science Editing. 2018;44(4):76-79. read 9 October 2026. europeanscienceediting.org.uk
  11. Bannas P, Reeder SB. How to write an original radiological research manuscript. European Radiology. 2017;27(11):4455-4460. doi:10.1007/s00330-017-4879-8 read 9 October 2026. doi.org/10.1007/s00330-017-4879-8
  12. Wager E, Woolley K, Adshead V, Cairns A, Fullam J, Gonzalez J, Grant T, Tortell S. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey. BMJ Open. 2014;4(4):e004780. doi:10.1136/bmjopen-2013-004780 read 9 October 2026. doi.org/10.1136/bmjopen-2013-004780
  13. Nagdev KJ, Agrawal AR. Key factors a pharmaceutical company should consider while outsourcing medical writing services. Medical Writing. 2014;23(3):223-227. read 9 October 2026. emwa.org
  14. von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement: guidelines for reporting observational studies. International Journal of Surgery. 2014. doi:10.1016/j.ijsu.2014.07.013 read 9 October 2026. doi.org/10.1016/j.ijsu.2014.07.013
  15. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology. 2011;64(4):383-394. read 9 October 2026. link.springer.com
  16. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1). doi:10.1186/1745-6215-11-32 read 9 October 2026. doi.org/10.1186/1745-6215-11-32
  17. Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ. 2008;337:a288. read 9 October 2026. link.springer.com
  18. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. read 9 October 2026. link.springer.com
  19. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. doi:10.1136/bmj.39335.541782.AD read 9 October 2026. doi.org/10.1136/bmj.39335.541782.AD
  20. Kliewer MA. Writing it up: a step-by-step guide to publication for beginning investigators. American Journal of Roentgenology. 2005;185:591-596. read 9 October 2026. tech.snmjournals.org
  21. Sollaci LB, Pereira MG. The Introduction, Methods, Results, and Discussion (IMRAD) structure: a fifty-year survey. Journal of the Medical Library Association. 2004;92(3):364-371. read 9 October 2026. genreacrossborders.uwaterloo.ca
  22. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Annals of Internal Medicine. 1997;126(1):36-47. read 9 October 2026. stat.cmu.edu
  23. Vickery B. The Royal Society Scientific Conference of 1948. Journal of Documentation. 1992;54(3):281-283. read 9 October 2026. stat.cmu.edu
  24. Atkinson D. The evolution of medical research writing from 1735 to 1985: the case of the Edinburgh Medical Journal. Applied Linguistics. 1992;13(4):337-374. read 9 October 2026. stat.cmu.edu
  25. Huth EJ. Structured abstracts for papers reporting clinical trials. Annals of Internal Medicine. 1987;106(4):626-627. read 9 October 2026. stat.cmu.edu
  26. Meadows AJ. The scientific paper as an archaeological artifact. Journal of Information Science. 1985;11(1):27-30. read 9 October 2026. stat.cmu.edu
  27. Bazerman C. Modern evolution of the experimental report in physics: spectroscopic articles in Physical Review, 1893-1980. Social Studies of Science. 1984;14:163-196. read 9 October 2026. stat.cmu.edu
  28. Radiology (Radiological Society of North America). Radiology scientific style guide and author instructions: scientific editing. Radiology. read 9 October 2026. pubs.rsna.org
  29. Fernandez E, Garcia AM, Seres E, Bosch F. Students' satisfaction and perceived impact on knowledge, attitudes and skills after a 2-day course in scientific writing: a prospective longitudinal study in Spain. BMJ Open. 8(1):e018657. read 9 October 2026. bmjopen.bmj.com

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 9). Common Mistakes in Medical Writing for Clinical Research: Reporting Errors and Their Prevention. Pubrica. https://pubrica.com/academy/medical-writing/what-are-the-common-mistakes-in-medical-writing-for-clinical-research/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Error audit for a draft manuscript

This audit should be completed with the manuscript open. Each line corresponds to an error described above. Answers should be written down rather than considered mentally; the lines that cannot be answered are those a reviewer is likely to raise.

MEDICAL WRITING MISTAKE AUDIT
Manuscript: ______________________   Target journal: ______________________

1. THE CLAIM
   My claim, in one sentence:
     __________________________________________________________
   The design feature that entitles me to make it:
     __________________________________________________________
   [ ] No causal verb ("improves", "demonstrates", "causes") unless the
       design is experimental
   [ ] No recommendation stronger than the evidence (one cohort does not
       justify "should be implemented routinely")
   [ ] No sentence whose hedging leaves nothing to assess

2. METHODS
   [ ] "Appropriate statistical tests" does not appear anywhere
   [ ] Named test stated per outcome
   [ ] Analysis population named (ITT / per protocol / complete case)
   [ ] Missing-data handling stated
   [ ] Multiple-testing approach stated, or explicitly none
   [ ] Allocation or sampling described well enough to be judged
   [ ] Every instrument named WITH its validation status
   [ ] Registration identifier present in the methods text
   [ ] Ethics approval and consent statements present
   [ ] Reporting guideline used: ______________________
       Unmet items: ______________________

3. OUTCOMES AND RESULTS
   [ ] Primary outcome named as primary
   [ ] Primary outcome reported FIRST
   [ ] Every analysis labelled pre-specified or exploratory
   [ ] Every subgroup claim accompanied by its interaction test
   [ ] Composite outcomes reported with their components
   [ ] No interpretation anywhere in the results section
   [ ] No number in the discussion that is absent from the results

4. ABSTRACT, TITLE, KEYWORDS
   [ ] Title names a finding or a design, not just a topic
   [ ] Abstract contains the primary outcome AS A NUMBER
   [ ] Design, setting and sample size all present in the abstract
   [ ] Conclusion does not exceed the result
   [ ] Keywords add terms absent from the title

5. DISCUSSION
   [ ] Principal finding restated without new numbers
   [ ] Most obvious alternative explanation named and addressed
   [ ] Each limitation given a DIRECTION of likely bias:
         limitation ______________ biases the estimate ______________
         limitation ______________ biases the estimate ______________
   [ ] Next step scaled to the evidence

6. LENGTH
   Journal total: ______   Current draft: ______
   [ ] Budget set per section BEFORE drafting
   [ ] Reference count within limit

7. ATTRIBUTION AND DISCLOSURE
   [ ] Every listed author meets all four ICMJE criteria
   [ ] Everyone who contributed but does not qualify is acknowledged
   [ ] Writing support, if used, named in the acknowledgements
   [ ] Funding and conflicts declared
   [ ] References verified against originals, not a manager export
   [ ] No unquoted reuse of my own earlier text

8. SORTING
   Problems found that WRITING can fix .............. ____
   Problems found that were SETTLED AT DESIGN ....... ____
   (If the second number is large, decide about the venue before editing.)

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica reviews a draft as a desk editor would, beginning with the title, abstract and methods, and returns the objections a reviewer is likely to raise while there is still time to address them. Pubrica distinguishes what revision of the writing can correct from what was determined when the study was designed, and states which is which. Where the analysis itself, rather than its description, is the weakness, Pubrica’s biostatisticians review it directly.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Pubrica can review a draft and distinguish errors that remain correctable from those determined by the study design.

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.